HJF Investments

HJF has invested in 1 company and its latest investment was Centivax on Jun 01, 2021

COMPANY

DESCRIPTION

AMOUNT

INVESTMENT DATE

ROUND

EXIT DATE

Centivax is a California-based broad-spectrum vaccine platform that offers pre-clinical drug development solutions for the treatment of viral infections.
$4.2M
Jun 01, 2021
-